Product: Max Ortho-K Lens
Top Line: Euclid Systems Corp., a global leader in advanced orthokeratology and proactive myopia management, announced the U.S. launch of the latest advance in overnight orthokeratology, Euclid Max. The new lens combines outstanding material characteristics with proven Euclid designs, according to the company, which has decades of experience developing proprietary Ortho-K algorithms and over two million lenses on eyes.
Close Up: Used in children and adult patients with progressive myopia (nearsightedness), but especially children, Ortho-K contact lenses gently reshape the cornea to manage myopia while the patient sleeps. This technology is especially important today with almost five billion people expected to have myopia by 2050, which would make it the leading cause of blindness worldwide. If left untreated, myopia significantly increases the risk of more serious ocular conditions including glaucoma, cataracts, and retinal disease.
“Euclid Max is the next generation of Ortho-K,” explained Euclid Systems CEO Joseph Boorady. “Building on Euclid’s proprietary lens designs, Euclid Max features an innovative material with a Hyper Dk of 180, the highest of any US overnight Ortho-K brand, without the compromise of lens stability. This is especially important with young healthy eyes in the closed eye environment. We are very proud and excited to introduce this combination of outstanding material characteristics and proven lens designs, which will help more patients successfully manage their myopia.”
Vital Stats: Following U.S. FDA approval, Euclid gave early access to Euclid Max to a limited group of optometrists spread across the country over the last few months to get real-world clinical experience on patients’ eyes.  In a survey of this early access group who had experience fitting the lens, 100 percent of the respondents replied they would consider recommending Euclid Max to their next patient. “Euclid Max provides incredible oxygen permeability, lens stability, and wettability, which adds a layer of comfort, safety, and satisfaction to my Ortho-K practice,” said David Kading, OD, FAAO, of Specialty Eyecare Group and an early access participant.
Euclid will host two live roundtable discussions focused on innovation with today’s top Ortho-K practitioners.  “Shifting the Paradigm: Maximize Performance with the Next Generation of Ortho-K Lenses” will be held on Wednesday, May 19, and Thursday, May 20. For more details and to register for either or both sessions, go to https://tinyurl.com/9pfcz8un; www.euclidsys.com; sales@euclidsys.com